
A new drug for hot flushes and night sweats has been approved for use in the UK, with availability from January 2024.
Veoza - or fezolinetant - is a pill designed to alleviate hot flushes, one of the most disruptive menopause symptoms, by working on the brain's temperature control centre. Unlike other effective treatments, this drug is not a hormonal option, making it an alternative to hormone replacement therapy (HRT) for those in need.